58 results
SD
STVN
Stevanato Group Spa
31 May 24
Conflict minerals disclosure
4:30pm
of products, processes and services that address customer needs across the entire drug life cycle from development to clinical and commercial stages
6-K
EX-99.1
STVN
Stevanato Group Spa
28 May 24
Current report (foreign)
4:10pm
customer needs across the entire drug life cycle from development to clinical and commercial stages. Stevanato Group’s core capabilities in scientific
6-K
EX-99.1
STVN
Stevanato Group Spa
24 May 24
Stevanato Group Announces Results of Annual General Meeting
4:51pm
-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle from development to clinical
6-K
EX-99.6
STVN
Stevanato Group Spa
14 May 24
Current report (foreign)
4:40pm
, Group’s life cycle and strategic priorities.
In particular, the report provides information on the (a) balance between fixed and variable
6-K
EX-99.3
STVN
Stevanato Group Spa
14 May 24
Current report (foreign)
4:40pm
development through life-cycle management. Our commitment is to cooperate deeply with our partners all over the world, providing our extensive know-how … the entire drug life cycle at each of the development, clinical and commercial stages. SYSTEMS PROCESSES SERVICES DrugSolutions Containment In-Medical Vitro
6-K
jnekmc1qeles6dec1
9 May 24
Current report (foreign)
4:10pm
6-K
EX-99.1
pvcxuly
9 May 24
Stevanato Group Reports Financial Results for the First Quarter of 2024
4:05pm
6-K
EX-99.1
9rf4jt 8qu9
26 Mar 24
Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares
6:10pm
6-K
EX-99.1
4ri0m8
25 Mar 24
Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares
4:23pm
424B5
lghn321l
25 Mar 24
Prospectus supplement for primary offering
4:04pm
6-K
EX-99.1
h0ldfrkv
20 Mar 24
Stevanato Group Announces Public Offering of Ordinary Shares
5:34pm
424B5
no1zgee2f2
20 Mar 24
Prospectus supplement for primary offering
5:16pm
F-3ASR
38dxnturz59q
20 Mar 24
Automatic shelf registration (foreign)
4:44pm
6-K
EX-99.1
1yuosjaxm7qws8b0t
7 Mar 24
Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023
4:00pm
6-K
EX-99.1
8j4y4oqtd urva
9 Nov 23
Current report (foreign)
4:00pm
6-K
lknpah6z
3 Nov 23
Current report (foreign)
4:00pm
6-K
EX-99.1
y2arq92j2 mjl2nsk57x
31 Oct 23
Stevanato Group Reports Third Quarter 2023 Financial Results
11:45am
6-K
EX-99.1
k5mta
6 Oct 23
Stevanato Group Announces Voting Results from its Extraordinary General Meeting
5:29pm
6-K
EX-99.1
bcg5nnncui r4
28 Sep 23
Current report (foreign)
9:31am